Simplex Trading’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7
Closed 10852
2022
Q3
$0 Sell
7
-60
-90% -$298 ﹤0.01% 11233
2022
Q2
$0 Sell
67
-20
-23% -$130 ﹤0.01% 11479
2022
Q1
$0 Buy
87
+20
+30% +$187 ﹤0.01% 11721
2021
Q4
$0 Sell
67
-201
-75% -$3.01K ﹤0.01% 11738
2021
Q3
$10K Hold
268
﹤0.01% 8958
2021
Q2
$10K Buy
+268
New +$11.7K ﹤0.01% 9126

Other funds holding LMNL

Simplex Trading's LMNL Position: Q4 2022 in Review

Simplex Trading sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q4 2022, closing a stake of 7 shares.

Simplex Trading first reported a position in LMNL in Q2 2021 and held it in 6 quarters. The position peaked at $10K in Q3 2021. 14 funds tracked by Wall St. Rank hold LMNL as of Q4 2022.

  • Simplex Trading reported no remaining Liminal BioSciences Inc. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 7 Liminal BioSciences Inc. Common Shares shares in Q4 2022.
  • Simplex Trading first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2021 and held it in 6 quarters.
  • Simplex Trading's Liminal BioSciences Inc. Common Shares position peaked at $10K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.